SCA
WGS icon

Southpoint Capital Advisors’s GeneDx Holdings WGS Stock Holding History

Southpoint Capital Advisors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,182
Closed -$8.93M – 71
2021
Q1 		$8.93M Buy
+18,182
New +$9.45M 0.14% 54

Other funds holding WGS

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Southpoint Capital Advisors's WGS Position: Q2 2021 in Review

Southpoint Capital Advisors sold out of GeneDx Holdings (WGS) in Q2 2021, closing a stake of 18,182 shares — an estimated $8.93M sold.

Southpoint Capital Advisors first reported a position in WGS in Q1 2021 and held it in 1 quarter. The position peaked at $8.93M in Q1 2021. 67 funds tracked by Wall St. Rank hold WGS as of Q2 2021.

  • Southpoint Capital Advisors reported no remaining GeneDx Holdings position as of Q2 2021 after selling out during the quarter.
  • Southpoint Capital Advisors sold 18,182 GeneDx Holdings shares in Q2 2021, an estimated $8.93M.
  • Southpoint Capital Advisors first reported a position in GeneDx Holdings in Q1 2021 and held it in 1 quarter.
  • Southpoint Capital Advisors's GeneDx Holdings position peaked at $8.93M in Q1 2021.
  • 67 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2021.

Based on Southpoint Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.